Approval · Notice of Compliance 5186 · 1995
PMS-NORTRIPTYLINE: Notice of Compliance 5186
Issued August 18, 1995
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 5186
- Date
- August 18, 1995
- Company
- Pharmascience Inc.Montreal, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Therapeutic class
- Antidepressant
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| PMS-NORTRIPTYLINE | 02177692 | Dormant |
| PMS-NORTRIPTYLINE | 02177706 | Dormant |
Medicinal ingredients
- NORTRIPTYLINE HCL 10 MG per CAP
- NORTRIPTYLINE HCL 25 MG per CAP